Sites and modes of action of an estrogen-gestagen combination on calcium and phosphate metabolism in postmenopausal osteoporosis.
D000284:Administration, Oral; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D000704:Analysis of Variance; D002118:Calcium / Q000097:blood / Q000378:metabolism* / Q000652:urine; D002127:Calcium Isotopes; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000378:metabolism; D003677:Deficiency Diseases / Q000150:complications; D004967:Estrogens / Q000378:metabolism / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D007408:Intestinal Absorption; D008593:Menopause; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy* / Q000209:etiology; D010710:Phosphates / Q000097:blood / Q000378:metabolism* / Q000652:urine; D010919:Placebos
D002127:Calcium Isotopes; D004967:Estrogens; D010710:Phosphates; D010919:Placebos; D003404:Creatinine; D000469:Alkaline Phosphatase; D006909:Hydroxyproline; D002118:Calcium